University of Zurich

Within the 'Department of Psychiatry, Psychotherapy and Psychosomatics' at the University of Zurich, Dr Milan Scheidegger is leading a team conducting psychedelic research and therapy development. Researchers here are investigating the therapeutic potential of psychedelics to reverse maladaptive neurobehavioral patterns in stress-related mood disorders and to enhance psychotherapeutic learning capabilities.

University of Zurich

Academic Research

Recent Papers

Quick Facts

Sponsored Trials

Effects of Intranasal Ketamine on Depression and Anxiety in Palliative Care Cancer Patients (Keta-Care)

Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction (Co-Boost)

Does Serotonin System Stimulation Increase Pro-social Behavior? – A Comparative Pharmacological Neuroscientific Study in Healthy Humans

Characterization of Altered Waking States of Consciousness in Healthy Humans

Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients

Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients – Proof of Concept

Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self

Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging

Research Papers

Ketamine-induced changes in accumbal glutamate and their association with altered states of consciousness

Company

Product

Legal